These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 396912)

  • 21. [Fendiline for hypodynamic coronary heart disease patients. Calmodulin antagonists--alternatives to calcium antagonism].
    Fortschr Med; 1985 Oct; 103(40):64. PubMed ID: 4065792
    [No Abstract]   [Full Text] [Related]  

  • 22. [Initial experience. Comparative study of verapamil and nifedipine in the treatment of coronary insufficiency. Evaluation by a cycloergometric test].
    Figueira RH; Guimarães F; Wagner M; Bozza AE; Dohmann HJ
    Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():39-43. PubMed ID: 354612
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of Sensit, a Ca++ antagonist, in ischaemic heart diseases.
    Antalóczy Z; Préda I
    Ther Hung; 1979; 27(2):71-6. PubMed ID: 494143
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cycloergometric evaluation of the continuous use of verapamil 360 mg/per day in chronic coronary insufficiency].
    Figueira RH; Bozza AE; Guimarães F; Terra LS; Silva O; Pereira E; Maiolino E; Dohmann HJ
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():55-8. PubMed ID: 329808
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of Sensit (fendiline) in angina pectoris.
    Böszörményi E; Ludvigh K; Fehér G; Schwarz J; Kármán M; Sziebert P
    Ther Hung; 1981; 29(3):134-7. PubMed ID: 7188139
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cycloergometric evaluation of the effects of verapamil in chronic coronary insufficiency].
    Meneghelo RS; Duprat R; Batlouni M; Severino CA; Armaganijan D; Magalhães HM; Feher J
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():59-63. PubMed ID: 329809
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effects of nitroglycerin on exercise hemodynamics in patients with coronary heart disease under treatment with beta-blockers (mepindolol, oxprenolol) and a calcium-antagonist (fendiline) (author's transl)].
    Reiterer W
    Wien Med Wochenschr; 1980 Dec; 130(23):772-7. PubMed ID: 6111161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cycloergometric evaluation of propatylnitrate in chronic coronary insufficiency].
    Armaganijan D; Batlouni M; Ghorayeb N; Dioguardi GS; Ogawa C
    Arq Bras Cardiol; 1980 Jan; 34(1):73-7. PubMed ID: 6996650
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical application of Sensit.
    Pálossy B
    Ther Hung; 1981; 29(4):171-5. PubMed ID: 6765146
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of fendiline on left-ventricular function evaluated by the echocardiographic method and on physical work capacity of patients with stable angina pectoris].
    Markiewicz M; Wysokiński A; Rymar B; Trojnar R; Wójcik J; Sokoluk I
    Wiad Lek; 1987 Dec; 40(24):1664-8. PubMed ID: 3451600
    [No Abstract]   [Full Text] [Related]  

  • 31. Examination of the anti-anginous effect of Sensit in angina pectoris.
    Tóth K
    Ther Hung; 1986; 34(4):212-6. PubMed ID: 3449975
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of the calcium antagonist fendiline on digitalis-induced ischemic reactions in the ECG].
    Kababgi MD; Schneider KW; Deeg P
    Med Welt; 1980 Jun; 31(25):959-62. PubMed ID: 7421525
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparative study of the medium term use of verapamil and perhexiline in the treatment of chronic coronary insufficiency. Clinical and cycloergometric evaluation].
    Candau LA; Padilha JC; Tasca R; de Patta M; Weiskopf JS; Scherr C
    Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():51-62. PubMed ID: 678165
    [No Abstract]   [Full Text] [Related]  

  • 34. [Action of nifedipine on the response to exertion and on peripheral tissue oxygenation. Comparative study of healthy individuals and coronary insufficiency patients].
    Botas L; Freitas JP; Barroca JP; Proenca C; Pereira JM; Martins e Silva JA
    Rev Esp Cardiol; 1982; 35(5 Suppl 2):II75-81. PubMed ID: 6763270
    [No Abstract]   [Full Text] [Related]  

  • 35. [Calmodulin antagonists in general practice. Evaluation of the side-effect spectrum].
    Kartnik G
    Fortschr Med Suppl; 1986; 3():18-9. PubMed ID: 2870964
    [No Abstract]   [Full Text] [Related]  

  • 36. [New drug (Sensit) for the treatment of coronary disease in a double blind test].
    Pillen D
    Fortschr Med; 1974 Jun; 92(16):709-11. PubMed ID: 4600940
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hemodynamic and humoral effects of fendiline, a calcium antagonist drug, in idiopathic hypertension patients].
    Castellano M; Beschi M; Muiesan ML; Romanelli G; Muiesan G
    Cardiologia; 1984; 29(7-8):359-66. PubMed ID: 6542415
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effects of verapamil on the cycloergometric test in patients of coronary artery disease].
    Oliveira JM
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():71-4. PubMed ID: 329811
    [No Abstract]   [Full Text] [Related]  

  • 39. [Calcium antagonists and adenosine derivatives in the treatment of patients with chronic ischemic heart disease].
    Kuz'ko NV
    Vrach Delo; 1988 Oct; (10):16-9. PubMed ID: 3218185
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical effectiveness of depot nitroglycerin preparations in ischemic heart disease patients].
    Grigor'iants RA; Lupanov VP; Samoĭlenko LE; Lobova NM
    Ter Arkh; 1984; 56(4):67-70. PubMed ID: 6427964
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.